Prospective Phase II Study to Evaluate Response to Two Induction Courses (12 intravesical instillations) of BCG Therapy for High-risk Non–muscle-invasive Bladder Cancer-Reference-Cited by-同舟云学术

Prospective Phase II Study to Evaluate Response to Two Induction Courses (12 intravesical instillations) of BCG Therapy for High-risk Non–muscle-invasive Bladder Cancer

Published:2021-11 Issue: Volume:157 Page:197-200
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Herr Harry,Vertosick Emily A.,Dalbagni Guido,Cha Eugene K,Smith Robert,Benfante Nicole,Sjoberg Daniel D.,Sfakianos John P

Funder

Memorial Sloan Kettering Cancer Center

Publisher

Elsevier BV

Subject

Urology

Reference15 articles.

1. Maintenance BCG immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized southwest oncology group study;Lamm;J Urol,2000

2. Defining BCG refractory superficial bladder tumors;Herr;J Urol,2003

3. Superficial bladder cancer treated with BCG: a multivariate analysis of factors affecting tumor progression;Herr;J Urol,1989

4. Bacillus Calmette-Guerin without maintenance therapy for high-risk non-muscle-invasive bladder cancer;Herr;Eur Urol,2011

5. Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer;Lerner;Urol Oncol,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to 2 Induction Courses of Bacillus Calmette-Guèrin Therapy Among Patients With High-Risk Non–Muscle-Invasive Bladder Cancer;JAMA Oncology;2024-04-01

2. Quinolone Prophylaxis in Conjunction with Bacillus Calmette-Guérin Instillations for Bladder Cancer: Time To Reconsider the Evidence and Open the Quinolone Box?;European Urology Focus;2023-11

3. Case Report: Step-by-step procedures for total intracorporeal laparoscopic kidney autotransplantation in a patient with distal high-risk upper tract urothelial carcinoma;Frontiers in Oncology;2023-04-24

4. BCG in Bladder Cancer Immunotherapy;Cancers;2022-06-23